Sun Pharmaceutical Industries recalls drugs from US market

31 Aug 2015 Evaluate

Sun Pharmaceutical Industries, a leading Indian pharmaceutical company has started voluntary recall of multiple lots of Bupropion Hydrochloride Extended-release Tablets USP (SR), 200 mg, 60-count bottle, from the US market for failed dissolution specification. According to a USFDA notification, Sun Pharma's recall was initiated last month under Class-III classification which was as 'a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences'. Approximately 35,235 bottles (60 count) of Bupropion Hydrochloride extended-release tablets distributed by the company have been recalled.

Sun Pharma is the world's fifth largest specialty generic pharmaceutical company and India's top pharmaceutical company. A vertically integrated business, economies of scale and an extremely skilled team enable us to deliver quality products in a timely manner at affordable prices. It provides high-quality, affordable medicines trusted by customers and patients in over 150 countries across the world.

Sun Pharma Inds. Share Price

1727.90 7.50 (0.44%)
02-Jan-2026 10:35 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1727.90
Dr. Reddys Lab 1245.60
Cipla 1507.75
Zydus Lifesciences 915.35
Lupin 2112.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×